Core Insights - UMeWorld Limited is expanding its flagship product, DAGola™, a clinically validated cooking oil that utilizes advanced enzymatic technology to produce high-purity diacylglycerol (DAG) [1][9] Product Overview - DAGola™ is formulated to meet the increasing global demand for healthier cooking oils, supporting fat metabolism and clinically proven to reduce triglycerides and lower uric acid levels, which are critical markers for metabolic syndrome, obesity, and gout [2][6] Market Expansion - DAGola™ is now available on Walmart Marketplace and Amazon, providing access to approximately 80% of online grocery shoppers in the U.S., which is expected to significantly boost U.S. revenue in Q4 2025 [3][7] - In China, UMeWorld is collaborating with leading national distributors to launch DAGola™ across online and offline channels, targeting the $25 billion edible oil market [5][8] Marketing Strategy - The company is initiating a targeted micro-influencer marketing program to enhance brand awareness and drive product trials, with plans to secure shelf space in mass-market retail chains [4][7] Scientific Validation - Clinical studies indicate that DAGola™ can reduce postprandial triglyceride formation by up to 80%, improve lipid metabolism, and support cardiovascular and metabolic health, positioning it favorably in the global edible oil market [6][9] Future Outlook - UMeWorld is well-positioned to execute its 2025 commercial roadmap, with expectations of significant contributions to top-line growth and global brand equity [7] - The company is also pursuing international expansion opportunities in Europe and Japan, aiming to leverage strategic partnerships and localized marketing initiatives [8]